Literature DB >> 2989612

Rare association of herpes simplex virus IgM-specific antibodies and Guillain-Barré syndrome successfully treated with plasma exchange and immunosuppression.

G Gerken, F Trautmann, H Köhler, D Falke, J Bohl, W Nix, K H Meyer zum Büschenfelde.   

Abstract

Herpes simplex virus (HSV) has been associated with various neurological disorders. In contrast, HSV infection is very rarely found in acute polyneuroradiculitis. In this report, a patient is described with a severe course of Guillain-Barr¿ syndrome (GBS). HSV IgM-specific antibodies and a rise of complement-fixation antibodies were detected. During the acute phase of neurologic syndrome, a nerve biopsy showed myelin damage and IgM deposits on the inner layer of the perineurium. Plasma exchange, in combination with immunosuppression, was successfully applied as a treatment in the relapsing course of GBS. Finally, after recovery, HSV-specific IgM antibodies disappeared.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989612     DOI: 10.1007/bf01731495

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  [ON SEROLOGIC RELATIONS OF B-VIRUS AND HERPES SIMPLEX VIRUS IN COMPLEMENT FIXATION REACTION].

Authors:  D FALKE
Journal:  Z Hyg Infektionskr       Date:  1964-12-03

2.  Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy.

Authors:  R J Greenwood; J Newsom-Davis; R A Hughes; S Aslan; A N Bowden; D W Chadwick; N S Gordon; D L McLellan; P Millac; R B Stott
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

3.  Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.

Authors:  P O Osterman; J Fagius; G Lundemo; P Pihlstedt; R Pirskanen; A Sidén; J Säfwenberg
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

4.  Demyelinative neuropathy and myelin antibodies.

Authors:  A K Asbury; R P Lisak
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

Review 5.  Current concepts in neurology. The causes, classification, and treatment of peripheral neuropathy.

Authors:  P J Dyck
Journal:  N Engl J Med       Date:  1982-07-29       Impact factor: 91.245

6.  Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation.

Authors:  J D Pollard; J G McLeod; P Gatenby; H Kronenberg
Journal:  J Neurol Sci       Date:  1983-02       Impact factor: 3.181

7.  Treatment of acute inflammatory polyneuropathy.

Authors:  R A Hughes; M Kadlubowski; A Hufschmidt
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422

8.  Guillain-Barré syndrome: its epidemiology and associations with influenza vaccination.

Authors:  L B Schonberger; E S Hurwitz; P Katona; R C Holman; D J Bregman
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422

9.  the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome.

Authors:  S D Cook; P C Dowling
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422

10.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  3 in total

1.  Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.

Authors:  H J Bernsen; A M Van Loon; R F Poels; W I Verhagen; C W Frenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 2.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

3.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.